Viracta Therapeutics, Inc.(VIRX)_个股概要_股票价格_最新资讯_行情走势_历史数据

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

VIRX Viracta Therapeutics, Inc.

已收盘 05-13 16:00:00 EDT

0.7710

+0.0110

+1.45%

盘后0.7700

-0.0010-0.13%

16:30 EDT

最高0.8100	最低0.7620	成交量4.01万
今开0.7900	昨收0.7600	日振幅6.32%
总市值3,028万	流通市值1,893万	总股本3,927万
成交额3.20万	换手率0.16%	流通股本2,455万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"VIRX","market":"US","secType":"STK","nameCN":"Viracta Therapeutics, Inc.","latestPrice":0.771001,"timestamp":1715630400000,"preClose":0.76,"halted":0,"volume":40061,"hourTrading":{"tag":"盘后","latestPrice":0.77,"preClose":0.771001,"latestTime":"16:30 EDT","volume":500,"amount":385,"timestamp":1715632204178},"delay":0,"floatShares":24551562,"shares":39272434,"eps":-1.235558,"marketStatus":"已收盘","marketStatusCode":5,"change":0.011001,"latestTime":"05-13 16:00:00 EDT","open":0.79,"high":0.81,"low":0.762,"amount":31971.39694,"amplitude":0.063158,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.235558,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1715673600000},"adr":0,"listingDate":1127793600000,"adjPreClose":0.76,"postHourTrading":{"tag":"盘后","latestPrice":0.77,"preClose":0.771001,"latestTime":"16:30 EDT","volume":500,"amount":385,"timestamp":1715632204178},"volumeRatio":0.857154},"requestUrl":"/m/hq/s/VIRX","defaultTab":"news","newsList":[{"id":"2432758259","title":"Viracta Therapeutics Inc    预计每股亏损 35 美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2432758259","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2432758259?lang=zh_cn&edition=full","pubTime":"2024-05-03 19:49","pubTimestamp":1714736942,"startTime":"0","endTime":"0","summary":"   * Viracta Therapeutics Inc    预计在5月6日公布截至2024年3月31日的财报时，季度营收将不会有任何变化(预计)    *    * LSEG分析师对Viracta Therapeutics Inc的平均预期是每股亏损35美分。* 华尔街对 Viracta Therapeutics Inc 的 12 个月目标价中位数为 5.50 美元，高于其最新收盘价 0.84 美元。5月3日 - 上一季度业绩。除非另有说明，否则所有数据均以美元为单位。(如对本报告中的数据有任何疑问，请联系 Estimates.Support@lseg.com。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.viracta.com","stockEarnings":[{"period":"1week","weight":-0.062},{"period":"1month","weight":-0.3333},{"period":"3month","weight":0.2258},{"period":"6month","weight":0.3103},{"period":"1year","weight":-0.3391},{"period":"ytd","weight":0.3333}],"compareEarnings":[{"period":"1week","weight":0.0187},{"period":"1month","weight":0.0131},{"period":"3month","weight":0.0392},{"period":"6month","weight":0.1821},{"period":"1year","weight":0.2638},{"period":"ytd","weight":0.0958}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Viracta Therapeutics, Inc.于1998年2月10日在特拉华州注册成立。其子公司主要位于南旧金山、加利福尼亚州。Viracta是一家精准肿瘤学公司，主要针对与病毒相关的恶性肿瘤。Viracta的专有研究药物Nanatinostat，目前正在与抗病毒药valganciclovir组合作为口服联合疗法在EBV阳性淋巴瘤的2期临床试验中进行评估。Viracta正在将这种可诱导的合成致死性方法应用于其他与EBV相关的恶性肿瘤，例如鼻咽癌，胃癌和其他与病毒相关的癌症。","yearOnYearQuotes":[{"month":1,"riseRate":0.473684,"avgChangeRate":0.07126},{"month":2,"riseRate":0.631579,"avgChangeRate":0.143175},{"month":3,"riseRate":0.526316,"avgChangeRate":0.062681},{"month":4,"riseRate":0.526316,"avgChangeRate":-0.003931},{"month":5,"riseRate":0.315789,"avgChangeRate":-0.000241},{"month":6,"riseRate":0.333333,"avgChangeRate":-0.022276},{"month":7,"riseRate":0.5,"avgChangeRate":-0.021177},{"month":8,"riseRate":0.388889,"avgChangeRate":0.000699},{"month":9,"riseRate":0.166667,"avgChangeRate":-0.110622},{"month":10,"riseRate":0.315789,"avgChangeRate":-0.123636},{"month":11,"riseRate":0.421053,"avgChangeRate":-0.026744},{"month":12,"riseRate":0.315789,"avgChangeRate":0.041195}],"exchange":"NASDAQ","name":"Viracta Therapeutics, Inc.","nameEN":"Viracta Therapeutics, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Viracta Therapeutics, Inc.(VIRX)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Viracta Therapeutics, Inc.(VIRX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Viracta Therapeutics, Inc.,VIRX,Viracta Therapeutics, Inc.股票,Viracta Therapeutics, Inc.股票老虎,Viracta Therapeutics, Inc.股票老虎国际,Viracta Therapeutics, Inc.行情,Viracta Therapeutics, Inc.股票行情,Viracta Therapeutics, Inc.股价,Viracta Therapeutics, Inc.股市,Viracta Therapeutics, Inc.股票价格,Viracta Therapeutics, Inc.股票交易,Viracta Therapeutics, Inc.股票购买,Viracta Therapeutics, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Viracta Therapeutics, Inc.(VIRX)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Viracta Therapeutics, Inc.(VIRX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}

公司概况